Clinical Trial Update: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating teclistamab with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy after autologous ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Teclistamab (teclistamab)

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING